Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 35 studies | 32% ± 16% | |
endothelial cell | 31 studies | 46% ± 19% | |
smooth muscle cell | 25 studies | 34% ± 13% | |
pericyte | 21 studies | 36% ± 17% | |
astrocyte | 15 studies | 44% ± 20% | |
oligodendrocyte precursor cell | 13 studies | 47% ± 20% | |
myofibroblast cell | 11 studies | 33% ± 16% | |
connective tissue cell | 11 studies | 37% ± 15% | |
glutamatergic neuron | 10 studies | 71% ± 17% | |
neuron | 10 studies | 64% ± 20% | |
basal cell | 10 studies | 38% ± 19% | |
adipocyte | 10 studies | 43% ± 11% | |
GABAergic neuron | 9 studies | 66% ± 20% | |
epithelial cell | 9 studies | 39% ± 17% | |
endothelial cell of lymphatic vessel | 9 studies | 37% ± 15% | |
mesothelial cell | 8 studies | 37% ± 13% | |
amacrine cell | 8 studies | 52% ± 19% | |
oligodendrocyte | 8 studies | 37% ± 13% | |
retinal ganglion cell | 7 studies | 77% ± 18% | |
ciliated cell | 7 studies | 25% ± 5% | |
club cell | 6 studies | 39% ± 17% | |
capillary endothelial cell | 6 studies | 33% ± 17% | |
retina horizontal cell | 6 studies | 47% ± 12% | |
type I pneumocyte | 6 studies | 47% ± 16% | |
type II pneumocyte | 6 studies | 40% ± 14% | |
abnormal cell | 5 studies | 31% ± 18% | |
endothelial cell of artery | 5 studies | 25% ± 9% | |
vein endothelial cell | 5 studies | 31% ± 15% | |
interneuron | 5 studies | 83% ± 12% | |
microglial cell | 5 studies | 50% ± 25% | |
cardiac muscle cell | 5 studies | 57% ± 9% | |
progenitor cell | 4 studies | 47% ± 14% | |
granule cell | 4 studies | 68% ± 6% | |
endothelial cell of vascular tree | 4 studies | 43% ± 18% | |
muscle cell | 4 studies | 43% ± 27% | |
goblet cell | 4 studies | 34% ± 28% | |
renal alpha-intercalated cell | 3 studies | 30% ± 9% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 47% ± 6% | |
neural crest cell | 3 studies | 23% ± 8% | |
glial cell | 3 studies | 41% ± 10% | |
macrophage | 3 studies | 40% ± 27% | |
GABAergic amacrine cell | 3 studies | 68% ± 10% | |
glycinergic amacrine cell | 3 studies | 59% ± 7% | |
hepatocyte | 3 studies | 74% ± 19% | |
chondrocyte | 3 studies | 43% ± 8% | |
respiratory goblet cell | 3 studies | 46% ± 16% | |
mucus secreting cell | 3 studies | 39% ± 11% | |
myoepithelial cell | 3 studies | 35% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 9596.41 | 245 / 245 | 100% | 27.97 | 501 / 502 |
breast | 100% | 8132.00 | 459 / 459 | 99% | 33.18 | 1112 / 1118 |
esophagus | 100% | 11007.50 | 1445 / 1445 | 99% | 31.43 | 182 / 183 |
lung | 100% | 7179.72 | 576 / 578 | 99% | 30.81 | 1149 / 1155 |
uterus | 100% | 18507.62 | 170 / 170 | 99% | 36.08 | 454 / 459 |
ovary | 100% | 14833.90 | 180 / 180 | 99% | 22.56 | 425 / 430 |
intestine | 100% | 12338.40 | 965 / 966 | 99% | 22.81 | 521 / 527 |
bladder | 100% | 12081.38 | 21 / 21 | 99% | 27.13 | 497 / 504 |
skin | 100% | 8540.82 | 1808 / 1809 | 98% | 40.49 | 462 / 472 |
thymus | 100% | 8808.72 | 653 / 653 | 98% | 30.65 | 591 / 605 |
stomach | 99% | 6729.52 | 356 / 359 | 98% | 24.76 | 281 / 286 |
kidney | 100% | 4504.06 | 89 / 89 | 97% | 27.99 | 875 / 901 |
brain | 95% | 11421.03 | 2518 / 2642 | 99% | 34.24 | 698 / 705 |
adrenal gland | 99% | 5563.46 | 256 / 258 | 95% | 34.62 | 218 / 230 |
liver | 99% | 3231.17 | 224 / 226 | 88% | 14.48 | 357 / 406 |
pancreas | 84% | 2333.91 | 277 / 328 | 98% | 30.43 | 175 / 178 |
adipose | 100% | 7597.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12767.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.36 | 1 / 1 |
muscle | 99% | 7573.41 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 5582.02 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 23.04 | 74 / 80 |
spleen | 90% | 2794.68 | 216 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 2.08 | 8 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016070 | Biological process | RNA metabolic process |
GO_0007399 | Biological process | nervous system development |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBFOX2 |
Protein name | RBFOX2 protein RNA-binding protein fox-1 homolog 2 RNA binding fox-1 homolog 2 (RNA-binding protein fox-1 homolog 2) RNA binding protein fox-1 homolog 2 RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity) RNA binding fox-1 homolog 2 |
Synonyms | RBM9 FOX2 HRNBP2 RTA |
Description | FUNCTION: RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Prevents binding of U2AF2 to the 3'-splice site. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis (By similarity). RNA-binding protein that seems to act as a coregulatory factor of ER-alpha. Together with RNA binding proteins RBPMS and MBNL1/2, activates vascular smooth muscle cells alternative splicing events . . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . |
Accessions | ENST00000695805.1 ENST00000262829.11 [O43251-3] ENST00000495377.6 ENST00000625456.2 A0A8Q3WKT3 ENST00000618140.3 [O43251-9] ENST00000438146.7 [O43251-8] ENST00000631365.2 [O43251-3] ENST00000695807.1 ENST00000695803.1 O43251 B0QYV1 ENST00000397305.3 A0A0G2JRA5 ENST00000449924.6 [O43251-10] ENST00000626107.2 [O43251-4] ENST00000397303.6 A0A8Q3SI20 ENST00000695806.1 A0A0G2JRD1 ENST00000473487.6 ENST00000630250.2 A0A8Q3SI19 A0A0G2JSB3 ENST00000408983.2 ENST00000629809.1 A0A8Q3SI58 ENST00000627872.2 A0A8Q3SI31 ENST00000627946.2 [O43251-5] ENST00000626598.2 ENST00000695804.1 A0A8Q3SI75 S4R469 B0QYY4 ENST00000695854.1 S4R3K7 ENST00000359369.8 B0QYY7 ENST00000416721.6 [O43251-5] F8WSN4 B0QYY6 ENST00000626165.1 ENST00000627612.2 ENST00000619768.4 [O43251-10] ENST00000405409.6 [O43251-9] ENST00000414461.6 [O43251-4] |